(Press-News.org) For nearly a decade, doctors have used an implanted electronic stimulator to treat severe depression in people who don't respond to standard antidepressant therapy.
Now, preliminary brain scan studies conducted by researchers at Washington University School of Medicine in St. Louis are beginning to reveal the processes occurring in the brain during stimulation and may provide some clues about how the device improves depression. They found that vagus nerve stimulation brings about changes in brain metabolism weeks or even months before patients begin to feel better.
The findings will appear in an upcoming issue of the journal Brain Stimulation and are now available online.
"Previous studies involving large numbers of people have demonstrated that many with treatment-resistant depression improve with vagus nerve stimulation," says first author Charles R. Conway, MD, associate professor of psychiatry. "But little is known about how this stimulation works to relieve depression. We focused on specific brain regions known to be connected to depression."
Conway's team followed 13 people with treatment-resistant depression. Their symptoms had not improved after many months of treatment with as many as five different antidepressant medications. Most had been depressed for at least two years, but some patients had been clinically depressed for more than 20 years.
All of the participants had surgery to insert a device to electronically stimulate the left vagus nerve, which runs down the side of the body from the brainstem to the abdomen. Once activated, the device delivers a 30-second electronic stimulus to the vagus nerve every five minutes.
To establish the nature of the treatment's effects on brain activity, the researchers performed positron emission tomography (PET) brain imaging prior to the initiation of stimulation, and again three and 12 months after stimulation had begun.
Eventually, nine of the 13 subjects experienced improvements in depression with the treatment. However, in most cases it took several months for improvement to occur.
AUDIO:
Implantable vagus nerve stimulators can relieve depression in some patients who can't be helped by standard antidepressant therapies. Now researchers at Washington University School of Medicine in St. Louis have...
Click here for more information.
Remarkably, in those who responded, the scans showed significant changes in brain metabolism following three months of stimulation, which typically preceded improvements in symptoms of depression by several months.
"We saw very large changes in brain metabolism occurring far in advance of any improvement in mood," Conway says. "It's almost as if there's an adaptive process that occurs. First, the brain begins to function differently. Then, the patient's mood begins to improve."
Although the patients remained on antidepressants for several months after their stimulators were implanted, Conway says many of those who responded to the device eventually were able to stop taking medication.
"Sometimes the antidepressant drugs work in concert with the stimulator, but it appears to us that when people get better, it is the vagus nerve stimulator that is doing the heavy lifting," Conway explains. "Stimulation seems to be responsible for most of the improvement we see."
Additionally, the PET scans demonstrated that structures deeper in the brain also begin to change several months after nerve stimulation begins. Many of those structures have high concentrations of brain cells that release dopamine, a neurotransmitter that helps control the brain's reward and pleasure centers and also helps regulate emotional responses.
There is a consensus forming among depression researchers that problems in dopamine pathways may be particularly important in treatment-resistant depression, according to Conway. And he says the finding that vagus nerve stimulators influence those pathways may explain why the therapy can help and why, when it does work, its effects are not transient. Patients who respond to vagus nerve stimulation tend to get better and to stay better.
"We hypothesized that something significant had to be occurring in the brain, and our research seems to back that up," he says.
INFORMATION:
Funding for this research comes from the National Institute of Mental Health (NIMH) and the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). Other funding was provided by a Young Investigator Award to Charles Conway from the National Alliance for Research in Schizophrenia and Affective Disorders (NARSAD) and the Sidney R. Baer Jr. Foundation. Cyberonics, the maker of the vagus nerve stimulation device, donated three cost-free devices to subjects in this trial.
NIH grant numbers are 1K08MH078156-01A1, 9K24MH07951006 and P30NS048056.
Conway CR, Chibnall JT, Gebara MA, Price JL, Snyder AZ, Mintun MA, Craig, AD, Cornell ME, Perantie DC, Giuffra LA, Bucholz RD, Sheline YI. Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression. Brain Stimulation, published online Feb. 2013: doi: 10.1016/j.brs.2012.11.006
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Nerve stimulation for severe depression changes brain function
2013-05-07
ELSE PRESS RELEASES FROM THIS DATE:
Initiation of breast cancer treatment varies by race; patient-doctor communication is key
2013-05-07
WASHINGTON — Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days — a time delay associated with increased deaths from the disease, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center.
But many women chose to forgo treatment altogether, and the study, published online in the May issue of Breast Cancer Research and Treatment, suggests that low satisfaction regarding communication between black women and their doctors is a significant reason ...
Decline in snow cover spells trouble for many plants, animals
2013-05-07
MADISON – For plants and animals forced to tough out harsh winter weather, the coverlet of snow that blankets the north country is a refuge, a stable beneath-the-snow habitat that gives essential respite from biting winds and subzero temperatures.
But in a warming world, winter and spring snow cover in the Northern Hemisphere is in decline, putting at risk many plants and animals that depend on the space beneath the snow to survive the blustery chill of winter.
In a report published May 2 in the journal Frontiers in Ecology and the Environment, a team of scientists ...
Study: MicroRNA cooperation mutes breast cancer oncogenes
2013-05-07
A University of Colorado Cancer Center study recently published in the journal Cell Death & Disease shows that turning up a few microRNAs a little may offer as much anti-breast-cancer activity as turning up one microRNA a lot – and without the unwanted side effects.
It's a bit like the classic thought experiment known as the "tumor problem" formulated by Karl Dunker in 1945 and used frequently in the problem-solving literature: Imagine a person suffers from a malignant tumor in the center of her body. Radiation strong enough to kill the tumor kills any healthy tissue ...
ER visits for urinary tract infections add almost $4 billion a year in unnecessary costs
2013-05-07
SAN DIEGO – Giving patients better access to primary health care could save nearly $4 billion a year in unnecessary emergency room visits for a single common complaint – urinary tract infections – according to a study by the Vattikuti Urology Institute at Henry Ford Hospital in Detroit.
The study set out to determine the economic burden of 10.8 million patients, with a primary diagnosis of urinary tract infection, who went to U.S. emergency rooms for treatment from the beginning of 2006 to the end of 2009.
The findings will be presented May 6 at the annual meeting of ...
Annals of Internal Medicine tip sheet for May 7, 2013
2013-05-07
1. Ambrisentan Not Appropriate for Patients with Idiopathic Pulmonary Fibrosis
Ambrisentan should not be used to treat patients for idiopathic pulmonary fibrosis (IPF). IPF is a fatal form of chronic, progressive lung disease characterized by irreversible scarring around both lungs. IPF causes about 5,000 deaths each year and currently there is no approved treatment. Researchers do not know what causes IPF, but a protein called endothelin-1 that causes the blood vessels to contract and induces lung scarring and proliferation has been associated with the disease. Researchers ...
MS may not be as rare as thought in African-Americans
2013-05-07
MINNEAPOLIS – Contrary to a widely accepted belief, African-Americans may have a higher rather than lower risk of developing multiple sclerosis (MS) than Caucasians, according to a new study in the May 7, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology.
"Our population-based study is the first of its kind to look at this question. The belief (that African- Americans have a lower risk of developing MS) was based on evidence that was problematic," said study author Annette Langer-Gould, MD, with Kaiser Permanente Southern California ...
Helping kids with severe respiratory failure survive until lung transplantation
2013-05-07
Minneapolis, MN, May 6, 2013 – Adults with end-stage respiratory failure and pulmonary hypertension requiring ECMO (extracorporeal membrane oxygenation) have been "bridged" toward lung transplantation with novel lung assist devices such as the Novalung. This and related devices work based on pumpless application of oxygenators. A presentation by David M. Hoganson, MD, and colleagues from Washington University School of Medicine in St. Louis at the Congenital Heart Disease Session of the 93rd AATS Annual Meeting describes the first time application of this technology to ...
Study finds black women have higher incidence of multiple sclerosis than white women
2013-05-07
PASADENA, Calif., May 6, 2013 – Multiple sclerosis is more common in black women than in white women, according to a Kaiser Permanente study published today in the journal Neurology. The findings run contrary to the widely accepted belief that blacks are less susceptible to MS, according to the researchers.
Researchers examined the electronic health records of more than 3.5 million members of Kaiser Permanente Southern California between January 2008 and December 2011 and identified 496 people newly diagnosed with MS. Of these diagnosed cases, black patients had a 47 ...
Medical innovation/quality improvement platform featured in Health Affairs
2013-05-07
Boston, Mass. –A quality improvement platform developed at Boston Children's Hospital could help health care provider groups continuously improve their medical practice, curbing costs and improving patient outcomes. Successful outcomes associated with the platform, called Standardized Clinical Assessment and Management Plans (SCAMPs) and supported by a consortium of Massachusetts payers, are featured in the May issue of Health Affairs.
SCAMPs start with existing practice recommendations, but are continuously revised as clinicians learn from everyday patient encounters. ...
Effects of stress on brain cells offer clues to new anti-depressant drugs
2013-05-07
Research from King's College London reveals the detailed mechanism behind how stress hormones reduce the number of new brain cells - a process considered to be linked to depression. The researchers identified a key protein responsible for the long-term detrimental effect of stress on cells, and importantly, successfully used a drug compound to block this effect, offering a potential new avenue for drug discovery.
The study, published in Proceedings of the National Academy of Sciences (PNAS) was co-funded by the National Institute for Health Research Biomedical Research ...